FDA
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Humana Inc. (NYSE: HUM); Jasper Therapeutics, Inc. (NASDAQ: JSPR); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law
-
-
-
-
-
-
-
Jasper Therapeutics Announces Appointment of Edwin J. Tucker, M.D., as Chief Medical Officer
-
-
-
-
-
-
-
Jasper Therapeutics (JSPR) Granted FDA Fast Track Designation for JSP191
-
-
-
-
-
-
-
Jasper Therapeutics (JSPR) Announces JSP191 Phase 1b MDS/AML Late Breaking Data Presentation at the 2022 Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR
-
-
-
-
-
-
-
After-Hours Stock Movers 10/12: (JSPR) (VST) (QCOM) Higher; (RGLS) (STIM) (RZLT) Lower (more...)
329,969 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

